Molecular Oncology Diagnostics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

Segmented By Product Type (Instruments, Kits and Assays, Software), By Technology (Fluorescence In-Situ Hybridization (FISH), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Flow Cytometry, and Other Technologies), By Application (Research, Clinical), By Cancer Type ({Solid Tumor (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, and Other Solid Tumors), Blood Cancers (Lymphoma, Leukemia, Multiple Myeloma, and other Hematological Malignancies)}, By End User (Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes), By Region

Published	Pages	Publisher	Report code
Jul 2023	111	TechSci Research	ASDR-623849

Published: Jul 2023 - Pages : 111 - Publisher : TechSci Research - Report code : ASDR-623849

1. Sysmex Corporation
2. F. Hoffmann-La Roche Ltd.
3. Myriad Genetics Inc.
4. HTG Molecular Diagnostics Inc.
5. Danaher Corporation.
6. QIAGEN N.V.
7. Bio-Rad Laboratories Inc.
8. Agilent Technologies Inc.
9. QIAGEN N.V.
10. Illumina Inc.

Molecular Oncology Diagnostics - Global Forecast 2024-2030

This report can be of interest as well:

Molecular Oncology Diagnostics - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-650830

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom